In AD patients, the cholesterol efflux activity of cerebrospinal fluid (CSF), which is mediated by both ABCG1 and ABCA1 and promotes transfer of cholesterol from astrocytes to neurons, was reported to be reduced (Marchi et al., 2019). This evidence concerns the gene ABCA1 and Alzheimer disease.